Grant: Project Grant
University of British Columbia
$688,500.00
Glycocalyx plasticity as an adaptive response to AR pathway-inhibition in prostate cancer
EF 2021-22
Résumé
Cancer cells are coated with sugar molecules that play important roles in cell-cell communication as well as cell-to-cell signaling. Tumor cells have the ability to reconfigure the sugar coat to support various aspects of disease progression. In prostate cancer, a portion of the sugar coat consists of chondroitin sulfate that is regulated by the male sex hormone androgen. Chondroitin sulfate becomes particularly important in the context of androgen-deprivation therapy and seems to be essential for tumor cell proliferation and motility under these conditions. This provides a strong rationale for studying chondroitin sulfate sugars in prostate cancer. In this project, we aim to investigate the role of the chondroitin sulfate coat during prostate cancer progression.
Programme
Project Grant
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
452453
Name
Daugaard Mads
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Molecular & Cellular Biology of Cancer
Projecttitle
Glycocalyx plasticity as an adaptive response to AR pathway-inhibition in prostate cancer
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$688,500
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Chondroitin Sulfate; Glycocalyx; Plasticity; Prostate Cancer
Abstract
Cancer cells are coated with sugar molecules that play important roles in cell-cell communication as well as cell-to-cell signaling. Tumor cells have the ability to reconfigure the sugar coat to support various aspects of disease progression. In prostate cancer, a portion of the sugar coat consists of chondroitin sulfate that is regulated by the male sex hormone androgen. Chondroitin sulfate becomes particularly important in the context of androgen-deprivation therapy and seems to be essential for tumor cell proliferation and motility under these conditions. This provides a strong rationale for studying chondroitin sulfate sugars in prostate cancer. In this project, we aim to investigate the role of the chondroitin sulfate coat during prostate cancer progression.
Competitiondate
202109
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Daugaard, Mads
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $688,500~ $0~